ERIC DOBMEIER Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and President, CEO in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
ERIC DOBMEIER in Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Chief Operating Officer, Chief Business Officer, Sr. VP, Corporate Development, V. P., Corporate Affairs, Vice President,
Holdings: 121,153 shares
Current Value: $7,364,891
Latest Transaction: Dec 06 2017
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ERIC DOBMEIER in Seagen Inc.
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 5.25 | 3,496 | 18,354 | 79,988 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 3.30 | 3,400 | 11,220 | 0 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 3.30 | 5,556 | 18,335 | 3,400 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 2.77 | 7,711 | 21,359 | 0 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | M | 2.77 | 2,704 | 7,490 | 7,711 | |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.90 | 3,400 | 30,260 | 1,798 | 5.2 K to 1.8 K (-65.41 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 3.30 | 3,400 | 11,220 | 5,198 | 1.8 K to 5.2 K (+189.10 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.91 | 5,556 | 49,504 | 1,798 | 7.4 K to 1.8 K (-75.55 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 3.30 | 5,556 | 18,335 | 7,354 | 1.8 K to 7.4 K (+309.01 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.91 | 7,711 | 68,705 | 1,798 | 9.5 K to 1.8 K (-81.09 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 2.70 | 7,711 | 20,820 | 9,509 | 1.8 K to 9.5 K (+428.87 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.92 | 2,704 | 24,120 | 1,798 | 4.5 K to 1.8 K (-60.06 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 2.77 | 2,704 | 7,490 | 4,502 | 1.8 K to 4.5 K (+150.39 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.92 | 11,470 | 102,312 | 1,798 | 13.3 K to 1.8 K (-86.45 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 11,470 | 60,218 | 13,268 | 1.8 K to 13.3 K (+637.93 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.93 | 700 | 6,251 | 1,798 | 2.5 K to 1.8 K (-28.02 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 700 | 3,675 | 2,498 | 1.8 K to 2.5 K (+38.93 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.95 | 4,135 | 37,008 | 1,798 | 5.9 K to 1.8 K (-69.69 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 4,135 | 21,709 | 5,933 | 1.8 K to 5.9 K (+229.98 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.98 | 4,300 | 38,614 | 1,798 | 6.1 K to 1.8 K (-70.51 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 4,300 | 22,575 | 6,098 | 1.8 K to 6.1 K (+239.15 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 8.99 | 3,496 | 31,429 | 1,798 | 5.3 K to 1.8 K (-66.04 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Buy | M | 5.25 | 3,496 | 18,354 | 5,294 | 1.8 K to 5.3 K (+194.44 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 9.00 | 6,328 | 56,952 | 1,798 | 8.1 K to 1.8 K (-77.87 %) |
Feb 13 2007 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Sell | S | 9.00 | 200 | 1,800 | 8,126 | 8.3 K to 8.1 K (-2.40 %) |
Sep 08 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 4.45 | 62,618 | 278,650 | 62,618 | |
Sep 08 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 4.45 | 17,382 | 77,350 | 17,382 | |
Feb 01 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.63 | 38,281 | 215,522 | 38,281 | |
Feb 01 2006 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.63 | 14,219 | 80,053 | 14,219 | |
Mar 03 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.07 | 46,351 | 235,000 | 46,351 | |
Mar 03 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Sr. VP, Corporate D ... | Option Exercise | A | 5.07 | 3,649 | 18,500 | 3,649 | |
Feb 02 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 5.92 | 29,165 | 172,657 | 29,165 | |
Feb 02 2005 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 5.92 | 10,835 | 64,143 | 10,835 | |
Aug 24 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 6.74 | 20,461 | 137,907 | 20,461 | |
Aug 24 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 6.74 | 4,539 | 30,593 | 4,539 | |
Jun 22 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 5.25 | 5,000 | 26,250 | 61,516 | |
Jun 22 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 5.25 | 5,000 | 26,250 | 5,300 | 300 to 5.3 K (+1,666.67 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 3.30 | 2,500 | 8,250 | 13,123 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 3.30 | 3,127 | 10,319 | 15,623 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 2.77 | 4,373 | 12,113 | 10,415 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 2.77 | 2,500 | 6,925 | 14,788 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | M | 2.77 | 2,500 | 6,925 | 17,288 | |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.70 | 2,500 | 21,750 | 300 | 2.8 K to 300 (-89.29 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 3.30 | 2,500 | 8,250 | 2,800 | 300 to 2.8 K (+833.33 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.60 | 4,373 | 37,608 | 300 | 4.7 K to 300 (-93.58 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 2.77 | 4,373 | 12,113 | 4,673 | 300 to 4.7 K (+1,457.67 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.55 | 2,500 | 21,375 | 300 | 2.8 K to 300 (-89.29 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 2.77 | 2,500 | 6,925 | 2,800 | 300 to 2.8 K (+833.33 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.60 | 3,127 | 26,892 | 300 | 3.4 K to 300 (-91.25 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 3.30 | 3,127 | 10,319 | 3,427 | 300 to 3.4 K (+1,042.33 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Sell | S | 8.50 | 2,500 | 21,250 | 300 | 2.8 K to 300 (-89.29 %) |
May 07 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Buy | M | 2.77 | 2,500 | 6,925 | 2,800 | 300 to 2.8 K (+833.33 %) |
Feb 19 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 10.33 | 18,229 | 188,306 | 18,229 | |
Feb 19 2004 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | V. P., Corporate Af ... | Option Exercise | A | 10.33 | 6,771 | 69,944 | 6,771 | |
Sep 03 2003 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Vice President, | Option Exercise | A | 5.81 | 29,917 | 173,818 | 29,917 | |
Sep 03 2003 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Vice President, | Option Exercise | A | 5.81 | 10,083 | 58,582 | 10,083 |